Novel Lauric Acid‐Butyric Structural Lipid Inhibits Inflammation: Small Intestinal Microbes May Be Important Mediators
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Wangxin Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Scope Butyric acid (C4) and lauric acid (C12) are recognized as functional fatty acids, while the health benefits of the structural lipids they constitute remain unclear. Methods and results In this study, lauric acid‐butyric structural lipid (S LBL ) is synthesized through ultrasound‐assisted enzyme‐catalyzed acidolysis and its health benefits are evaluated in a high‐fat diet‐induced obesity mouse model. S LBL and its physical mixture (M LBL ) do not significantly inhibit obesity in mice. However, S LBL treatment increases the ratio of n3/n6 fatty acids in the liver and improves obesity‐induced hepatic lipid metabolism disorders. Furthermore, the expression of liver pro‐inflammatory cytokines (interleukin [IL]‐6, IL‐1β, TNF‐α) are significantly suppressed by S LBL , while the expression of anti‐inflammatory cytokine (IL‐10) is increased. Moreover, S LBL ameliorates the dysbiosis of small intestinal microbes induced by high‐fat diet and regulates microbial community structure to be close to the control group. Especially, S LBL significantly alleviates the high‐fat diet‐induced decrease in Dubosiella and Bifidobacterium abundance. Correlation analysis reveals that S LBL treatment increases the abundance of microorganisms with potential anti‐inflammatory function and decreases the abundance of potentially pathogenic bacteria. Conclusion In all, small intestinal microbes may be a significant bridge for the positive anti‐inflammatory effects of S LBL , while the exact mechanism remains to be clarified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058, China.
- College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, China.
ORCID-Profile: Xianliang Luo
Förderung
- National Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Liu, W., Zhao, M., Huang, Y., Feng, F., & Luo, X. (2024). Novel Lauric Acid‐Butyric Structural Lipid Inhibits Inflammation: Small Intestinal Microbes May Be Important Mediators. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300535
Vancouver
Liu W, Zhao M, Huang Y, Feng F, Luo X. Novel Lauric Acid‐Butyric Structural Lipid Inhibits Inflammation: Small Intestinal Microbes May Be Important Mediators. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300535
BibTeX
@article{Liu2024,
author = {Liu, Wangxin and Zhao, Minjie and Huang, Ying and Feng, Fengqin and Luo, Xianliang},
title = {Novel Lauric Acid‐Butyric Structural Lipid Inhibits Inflammation: Small Intestinal Microbes May Be Important Mediators},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300535}
}
EUVIMED